Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-08-19
Original SEC Filing: Click here

---

Webplus: SVA/20140819/6-K/2_EX-99.1/000.htm SEC Original: v387240_ex99-1.htm
Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program BEIJING, July 21, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Health Bureau as the sole supplier of inactivated hepatitis A vaccine in pre-filled syringe dosage

---

---

Webplus: SVA/20140819/6-K/3_EX-99.2/000.htm SEC Original: v387240_ex99-2.htm
Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu BEIJING, July 23, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (“Beijing CDC”) to be a supplier of the seasonal influenza vaccine to the citizens

---

---

Webplus: SVA/20140819/6-K/4_EX-99.3/000.htm SEC Original: v387240_ex99-3.htm
Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results BEIJING, July 25, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company

---

---

Webplus: SVA/20140819/6-K/1/000.htm SEC Original: v387240_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-08-19CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085